The estimated Net Worth of Ronald W Penczek is at least $4.82 Million dollars as of 1 March 2022. Mr. Penczek owns over 2,423 units of Anthem Inc stock worth over $917,867 and over the last 9 years he sold ANTM stock worth over $3,901,442. In addition, he makes $0 as Senior Vice President, Chief Accounting Officer, and Controller at Anthem Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Mr. Penczek ANTM stock SEC Form 4 insiders trading
Ronald has made over 19 trades of the Anthem Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently he sold 2,423 units of ANTM stock worth $1,123,497 on 1 March 2022.
The largest trade he's ever made was exercising 2,763 units of Anthem Inc stock on 7 February 2022 worth over $714,236. On average, Ronald trades about 856 units every 81 days since 2016. As of 1 March 2022 he still owns at least 1,902 units of Anthem Inc stock.
You can see the complete history of Mr. Penczek stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Ronald Penczek biography
Ronald W. Penczek is a Senior Vice President, Chief Accounting Officer, Controller of the Company. Prior to that appointment, Mr. Penczek served as Vice President and Assistant Controller from January 2008 to August 2013 and in various other roles in our finance department from February 2006 until January 2008. Before joining us, Mr. Penczek was a Staff Vice President with CNA Insurance from 2000 to 2005 and had various positions with PricewaterhouseCoopers LLP from 1992 to 2000, including as a Manager.
How old is Ronald Penczek?
Ronald Penczek is 55, he's been the Senior Vice President, Chief Accounting Officer, and Controller of Anthem Inc since 2015. There are 18 older and 6 younger executives at Anthem Inc. The oldest executive at Anthem Inc is Julie Hill, 73, who is the Independent Director.
Insiders trading at Anthem Inc
Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider, and Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.
What does Anthem Inc do?
Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.
What does Anthem Inc's logo look like?
Complete history of Mr. Penczek stock trades at Anthem Inc
Anthem Inc executives and stock owners
Anthem Inc executives and other stock owners filed with the SEC include:
-
Gail Boudreaux,
President, Chief Executive Officer, Director -
Felicia Norwood,
Executive Vice President, President - Government Business Division -
Gloria McCarthy,
Executive Vice President, Chief Administrative Officer -
Gail Koziara Boudreaux,
Pres, CEO & Director -
John Gallina,
Chief Financial Officer, Executive Vice President -
Peter Haytaian,
Executive Vice President, President of Commercial and Specialty Business Division -
Thomas Zielinski,
Executive Vice President, General Counsel -
John Edward Gallina,
Exec. VP & CFO -
Gloria Marie McCarthy,
Exec. VP and Chief Admin. Officer -
Peter David Haytaian Esq.,
Exec. VP and Pres of Diversified Bus. & IngenioRx -
Felicia Farr Norwood,
Exec. VP & Pres of Gov. Bus. Division -
Elizabeth Tallett,
Independent Chairman of the Board -
Ramiro Peru,
Independent Director -
Julie Hill,
Independent Director -
Robert Dixon,
Independent Director -
Lewis Hay,
Independent Director -
R. Kerry Clark,
Independent Director -
Antonio Neri,
Independent Director -
Bahija Jallal,
Independent Director -
Ryan Schneider,
Independent Director -
Chris Rigg,
Vice President Investor Relations -
Ronald Penczek,
Senior Vice President, Chief Accounting Officer, Controller -
Prakash Patel,
Executive Vice President, President - Diversified Business Group -
Leah Stark,
Chief Human Resource Officer, Executive Vice President -
Stephen Vartan Tanal C.F.A.,
VP of Investor Relations -
Thomas H. Miller,
Sr. VP & Chief Information Officer -
Anil Bhatt,
Chief Technology Officer -
Ronald William Penczek,
Sr. VP, Controller & Chief Accounting Officer -
Scott Wayne Anglin,
SVP, Treasurer & Chief Investment Officer -
Joseph Swedish,
President & CEO -
William J Ryan,
Director -
George A Jr Schaefer,
Director -
Jose D. Tomas,
EVP & Chief HR Officer -
Jacquelyn H Wolf,
EVP & Chief HR Officer -
Craig E Samitt,
EVP & Chief Clinical Officer -
Wayne S De Veydt,
EVP & Chief Financial Officer -
Brian T Griffin,
EVP & President, CSBD -
Samuel R Md Nussbaum,
EVP & Chief Medical Officer -
Martin B Silverstein,
EVP & Chief Strategy Officer -
Kenneth R Goulet,
EVP, Commercial & Specialty -
Blair Williams Todt,
EVP and Chief Legal Officer -
Jeffrey D. Alter,
EVP, IngenioRx & Anthem Health -
Susan D. De Vore,
Director -
Charles Morgan Jr Kendrick,
EVP & President, Commercial